Compare NSPR & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSPR | REFR |
|---|---|---|
| Founded | 2005 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.4M | 54.8M |
| IPO Year | N/A | N/A |
| Metric | NSPR | REFR |
|---|---|---|
| Price | $1.63 | $1.15 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 35.3K | ★ 46.7K |
| Earning Date | 03-11-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,779,000.00 | $1,227,276.00 |
| Revenue This Year | $22.76 | N/A |
| Revenue Next Year | $75.45 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.04 | N/A |
| 52 Week Low | $1.51 | $0.93 |
| 52 Week High | $3.80 | $2.70 |
| Indicator | NSPR | REFR |
|---|---|---|
| Relative Strength Index (RSI) | 40.66 | 31.66 |
| Support Level | $1.53 | $1.21 |
| Resistance Level | $1.70 | $1.32 |
| Average True Range (ATR) | 0.11 | 0.08 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 45.65 | 5.77 |
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.